
R2 Technology Services
Medical system that develops and markets advanced technologies for cosmetic suppliers and customers.
Date | Investors | Amount | Round |
---|---|---|---|
$15.0m | Series C | ||
Total Funding | 000k |
Related Content
R2 Technologies operates in the medical device industry, focusing on dermatological solutions that modulate melanin production for advanced skin treatments. The company serves healthcare providers, dermatologists, and aesthetic clinics, primarily in the United States. R2 Technologies leverages cutting-edge research from Massachusetts General Hospital to develop its products. The business model revolves around the sale and distribution of its proprietary devices, as well as ongoing support and training for medical professionals. Revenue is generated through direct sales, partnerships, and service agreements. The company's leadership team comprises seasoned experts with extensive experience in medical devices, pharmaceuticals, and biotechnology, ensuring a robust and innovative approach to skin treatment solutions.
Keywords: dermatology, melanin modulation, skin treatment, medical devices, healthcare providers, aesthetic clinics, advanced technology, research-driven, revenue model, innovative solutions.